Literature DB >> 25757869

The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?

Karim Raza1, Andrew Filer2.   

Abstract

Entities:  

Keywords:  Arthritis; DMARDs (synthetic); Early Rheumatoid Arthritis; Rheumatoid Arthritis

Mesh：

Substances：

Year:  2015        PMID： 25757869     DOI： 10.1136/annrheumdis-2014-206993

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  19 in total

Review 1.  A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis.

Authors:  Vincenzo Venerito; Giuseppe Lopalco; Fabio Cacciapaglia; Marco Fornaro; Florenzo Iannone
Journal:  Clin Rheumatol       Date:  2019-01-10       Impact factor: 2.980

Review 2.  Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis.

Authors:  Jane Falconer; Anne N Murphy; Stephen P Young; Andrew R Clark; Stefano Tiziani; Monica Guma; Christopher D Buckley
Journal:  Arthritis Rheumatol       Date:  2018-06-04       Impact factor: 10.995

3.  Achievement of NICE quality standards for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.

Authors:  Joanna M Ledingham; Neil Snowden; Ali Rivett; James Galloway; Zoe Ide; Jill Firth; Elizabeth MacPhie; Ngianga Kandala; Elaine M Dennison; Ian Rowe
Journal:  Rheumatology (Oxford)       Date:  2016-10-01       Impact factor: 7.580

4.  Symptom Recognition and Perceived Urgency of Help-Seeking for Rheumatoid Arthritis and Other Diseases in the General Public: A Mixed Method Approach.

Authors:  Gwenda Simons; John Belcher; Chris Morton; Kanta Kumar; Marie Falahee; Christian D Mallen; Rebecca J Stack; Karim Raza
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-04-10       Impact factor: 4.794

5.  Rate of Proven Rheumatic Diseases in a Large Collective of Referrals to an Outpatient Rheumatology Clinic Under Routine Conditions.

Authors:  Martin Feuchtenberger; Axel Philipp Nigg; Michael Rupert Kraus; Arne Schäfer
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2016-10-02

6.  Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.

Authors:  Jayesh M Pandya; Anna-Carin Lundell; Kerstin Andersson; Inger Nordström; Elke Theander; Anna Rudin
Journal:  Arthritis Res Ther       Date:  2017-02-02       Impact factor: 5.156

7.  Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation.

Authors:  Khadija M Alawi; Fiona A Russell; Aisah A Aubdool; Salil Srivastava; Yanira Riffo-Vasquez; Lineu Baldissera; Pratish Thakore; Nurjahan Saleque; Elizabeth S Fernandes; David A Walsh; Susan D Brain
Journal:  Ann Rheum Dis       Date:  2016-05-10       Impact factor: 19.103

8.  Long-term outcomes of patients who rate symptoms of rheumatoid arthritis as 'satisfactory'.

Authors:  James M Gwinnutt; Kimme L Hyrich; Mark Lunt; Anne Barton; Suzanne M M Verstappen
Journal:  Rheumatology (Oxford)       Date:  2020-08-01       Impact factor: 7.580

Review 9.  Effectiveness of Remission Induction Strategies for Early Rheumatoid Arthritis: a Systematic Literature Review.

Authors:  M M A Verhoeven; P M J Welsing; J W J Bijlsma; J M van Laar; F P J G Lafeber; J Tekstra; J W G Jacobs
Journal:  Curr Rheumatol Rep       Date:  2019-04-23       Impact factor: 4.592

10.  Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis.

Authors:  Roy M Fleischmann; Tom W J Huizinga; Arthur F Kavanaugh; Bethanie Wilkinson; Kenneth Kwok; Ryan DeMasi; Ronald F van Vollenhoven
Journal:  RMD Open       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.